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Abstract
In Pseudomonas fluorescens Pf0-1 the availability of inorganic phosphate (Pi) is an environmental signal that controls biofilm
formation through a cyclic dimeric GMP (c-di-GMP) signaling pathway. In low Pi conditions, a c-di-GMP phosphodiesterase
(PDE) RapA is expressed, depleting cellular c-di-GMP and causing the loss of a critical outer-membrane adhesin LapA from
the cell surface. This response involves an inner membrane protein LapD, which binds c-di-GMP in the cytoplasm and exerts
a periplasmic output promoting LapA maintenance on the cell surface. Here we report how LapD differentially controls
maintenance and release of LapA: c-di-GMP binding to LapD promotes interaction with and inhibition of the periplasmic
protease LapG, which targets the N-terminus of LapA. We identify conserved amino acids in LapA required for cleavage by
LapG. Mutating these residues in chromosomal lapA inhibits LapG activity in vivo, leading to retention of the adhesin on the
cell surface. Mutations with defined effects on LapD’s ability to control LapA localization in vivo show concomitant effects
on c-di-GMP-dependent LapG inhibition in vitro. To establish the physiological importance of the LapD-LapG effector
system, we track cell attachment and LapA protein localization during Pi starvation. Under this condition, the LapA adhesin
is released from the surface of cells and biofilms detach from the substratum. This response requires c-di-GMP depletion by
RapA, signaling through LapD, and proteolytic cleavage of LapA by LapG. These data, in combination with the companion
study by Navarro et al. presenting a structural analysis of LapD’s signaling mechanism, give a detailed description of a
complete c-di-GMP control circuit—from environmental signal to molecular output. They describe a novel paradigm in
bacterial signal transduction: regulation of a periplasmic enzyme by an inner membrane signaling protein that binds a
cytoplasmic second messenger.
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Introduction
Bacteria can be exquisitely tuned to sense and respond to
changes in their environment. A single cell may possess an
immense repertoire of signal transduction systems capable of
receiving sensory input and directing physiological adaptation.
The recent groundswell of studies on the intracellular second
messenger cyclic dimeric GMP (c-di-GMP) has added a new
dimension to bacterial signaling. c-di-GMP controls major lifestyle
transitions for bacteria, promoting the shift from motile to sessile
modes of growth through impacts on diverse physiological outputs.
This molecule is synthesized by diguanylate cyclases (DGCs) [1],
proteins that contain the GGDEF domain, and can be degraded
by specific phosphodiesterases (PDEs) containing either the EAL
or HD-GYP domain [2,3]. Such domains are ubiquitous in
bacterial genomes, and occur in combination with an array of
sensory input and output modules [4].
A substantial body of work has identified specific DGCs and
PDEs that impact cell adhesion and biofilm formation in diverse
bacteria. The phenotypic effects of these signaling proteins include
changes in exopolysaccharide (EPS) production, motility, and
transcription [5]. Assigning c-di-GMP signaling activity to many
proteins, sometimes dozens within a single bacterium, has
highlighted the complexities of c-di-GMP signaling networks,
and has exacerbated the task of connecting specific environmental
signals to discrete outputs.
A key, recent advance in our understanding c-di-GMP’s role in
bacteria has been the identification of c-di-GMP receptors with
defined outputs. Receptors, or effector proteins, identified thus far
utilize a range of c-di-GMP binding mechanisms to impact EPS
synthesis [6,7,8], motility [9,10,11,12], transcription [13,14,15],
and sub-cellular [16] or cell-surface protein localization [17]. In a
few cases, molecular details of the effector’s output have been
determined. c-di-GMP binding to the PilZ domain of YcgR
stimulates its interaction with the flagellar complex of E. coli,
resulting in a counter-clockwise rotational bias and reduced
motility [18,19,20]. In V. cholerae, c-di-GMP binds the transcription
factor VpsT causing a change in its oligomerization and activity,
inversely regulating genes for rugosity and motility [15]. PopA of
C. crescentus undergoes dynamic localization to the cell pole upon c-
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[16]. In addition to binding effector proteins, c-di-GMP has also
been shown to bind riboswitches [21,22,23]. The diversity of these
control mechanisms, and their varied targets, highlights the scope
and intricacy of c-di-GMP signaling. Despite the significant
progress these studies represent, in most cases the environmental
or cellular inputs controlling the DGCs and/or PDEs that regulate
these effectors have yet to be defined.
Stable surface attachment and subsequent biofilm formation by
Pseudomonas fluorescens Pf0-1 requires a large adhesive protein,
LapA. This ,520 kD protein is secreted to the surface of the outer
membrane by an ABC transporter encoded by the lapEBC genes
[24]. LapA’s maintenance on the cell surface is controlled post-
translationally by the c-di-GMP binding protein LapD [17]. When
c-di-GMP levels are high, LapD binds c-di-GMP and promotes
biofilm formation via accumulation of LapA on the cell surface. In
the absence of c-di-GMP binding to LapD, LapA is released from
the cell rendering it unable to attach [17].
In a prior study, our group characterized LapD, reporting
genetic and biochemical evidence that LapD binds c-di-GMP
through its cytoplasmic EAL domain and controls biofilm
formation via a periplasmic output domain [17]. The structure/
function analysis presented by Newell et al. suggested that LapD
controls LapA localization by a unique inside-out signaling
mechanism: binding c-di-GMP in the cytoplasm and transmitting
this signal through the inner membrane to the periplasm via a
HAMP domain. Such a mechanism could account for how
changes in cytoplasmic c-di-GMP levels control LapA’s stability on
the cell surface post-translationally. However, the mechanism by
which LapD’s periplasmic domain impacted LapA localization
was unknown.
The availability of inorganic phosphate (Pi) is an important
environmental signal that governs biofilm formation by P.
fluorescens Pf0-1 via a c-di-GMP-dependent mechanism. When Pi
is limiting, the c-di-GMP PDE RapA is expressed and depletes
cellular c-di-GMP, suppressing biofilm formation [25]. One effect
of RapA’s activity is the loss of the adhesin LapA from the cell
surface. While our previous study showed that the effects of Pi
starvation and RapA expression on biofilm require signaling
through LapD [17], the specific contribution of LapD to changes
in LapA localization in this signaling pathway was not known.
Here we uncover how LapD controls LapA localization and
provide biochemical data describing its function as an inside-out
signaling protein. When bound to c-di-GMP, LapD inhibits the
activity of a periplasmic protease, LapG. In the absence of c-di-
GMP binding to LapD, LapG is free to cleave the N-terminus of
LapA, releasing the adhesin from the cell and preventing biofilm
formation. Upon Pi starvation, the LapD-LapG system responds to
c-di-GMP depletion by RapA and promotes biofilm detachment.
These data, in combination with the companion study by Navarro
et al. [26] presenting a structural analysis of LapD’s signaling
mechanism, describe a key connection in a complete c-di-GMP
control circuit that links environmental signal to cellular output.
Results
Note: The Supporting Information section includes an expand-
ed alignment of LapA-like proteins (Figure S1), a graphical
depiction of data describing inhibition of LapG activity by c-di-
GMP and additional data on LapG activity in the presence of
detergents (Figure S2), data describing the localization of control
proteins in the presence and absence of c-di-GMP (Figure S3), and
images of representative biofilm assays from the dataset depicted
graphically in Figure 7B (Figure S4).
Phenotypic and Genetic Analyses of the lapG Mutant
In this study, our objective was to determine the mechanism by
which the c-di-GMP effector LapD controls LapA localization. In
an effort to identify additional players in this pathway, we
investigated the function of a gene immediately upstream of lapD,
designated lapG. We deleted the lapG gene (Pfl_0130) and
determined the effects of this mutation on irreversible surface
attachment and biofilm formation. After 6 h in a static culture, the
lapG mutant (DlapG) showed a hyper-adherent biofilm phenotype,
accumulating twice as much biomass on the culture well as the
WT (Figure 1A). These strains were examined by microscopy
under similar, static growth conditions. After a 1-h incubation,
irreversibly attached DlapG cells covered twice as much of the
substratum as compared to the WT (Figure 1B). Through longer
incubation times, DlapG continued to show about twice as many
attached cells as WT (unpublished data). These results suggest that
increased cell attachment accounts for the biofilm phenotype of
DlapG.
To complement the lapG mutant we reintroduced the gene on a
multi-copy plasmid. This caused total loss of biofilm formation,
shown and discussed in more detail below. A second approach was
employed: restoring the lapG gene to its native locus in DlapG using
allelic replacement. The resulting strain, lapGREST, showed similar
levels of biofilm formation and surface attachment as WT
(Figure 1A,B). When a lapG allele carrying an internal HA epitope
tag (lapG-HA) was introduced into the lapG locus, this also restored
the WT phenotype (Figure 1A).
The adhesin LapA is the primary factor required by P. fluorescens
for attachment to surfaces under these conditions [17,24,25]. We
hypothesized that increased expression or cell surface localization
of LapA might account for the biofilm phenotype of DlapG. To test
these hypotheses, we examined LapA levels in cell extracts and
culture supernatants by Western blot, and on the surface of intact
cells by dot blot. Cell extracts of WT and DlapG showed similar
levels of LapA, suggesting comparable levels of LapA protein
expression in these strains (Figure 1C; 0.9860.05-fold change
from WT, n=3). Interestingly, the lapG mutant had a unique
Author Summary
Bacteria can live as free swimming cells or attached to
surfaces in communities called biofilms. The di-nucleotide
c-di-GMP is a key cytoplasmic signal that regulates biofilm
formation in a number of bacterial species. Our study, in
combination with structural analysis described in the
accompanying paper by Sondermann et al., describes
key interactions in a c-di-GMP signaling pathway that
allows cells of Pseudomonas fluorescens to adapt to
changes in the concentration of the nutrient phosphate
by regulating biofilm formation. The adhesion protein
LapA is localized outside the bacterial cell membrane and
is responsible for keeping cells attached to surfaces. We
show that under low phosphate conditions levels of c-di-
GMP are depleted in cells, and these changes are sensed
by LapD, a transmembrane c-di-GMP receptor protein.
When c-di-GMP levels are low, the LapD protein is kept in
an ‘‘off’’ state that allows LapG, a periplasmic protease, to
interact with LapA and cleave the N-terminal domain of
this adhesion, releasing LapA from the cell surface and
promoting biofilm detachment. Under abundant phos-
phate conditions, LapD binds c-di-GMP in the cytoplasm
and binds to and sequesters LapG in the periplasm,
promoting cell adhesion via maintenance of LapA on the
cell surface.
c-di-GMP Effector Controls Periplasmic Protease
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supernatant and a 2-fold increase in LapA on the cell surface
(Figure 1C,D). These data suggest that lapG is involved in the
release of LapA from the cell surface. The DlapG phenotypes are
consistent with previous data showing that cell-surface localization
of LapA has a direct and proportional stimulatory effect on biofilm
formation [17,27]. Restoration of either the WT or lapG-HA alleles
to the lapG locus of DlapG restored a WT LapA localization
phenotype (Figure 1C,D).
If increased adhesion by DlapG is caused by the aberrant
accumulation of LapA on the cell surface, then a mutation in lapA
should be epistatic to lapG. Introduction of a null mutation in lapA
into the DlapG mutant completely eliminated biofilm formation
(Figure 1E), a phenotype identical to that of a lapA mutant.
Figure 1. Phenotypic analyses of the lapG mutant. (A) A quantitative biofilm assay comparing the indicated strains. Crystal violet stained
biomass (pictured above) was dissolved and quantified by spectrophotometry at 550 nm. Data for all biofilm assays are presented as the mean 6 SD
for 8–12 replicates. (B) Initial surface attachment was visualized by phase contrast microscopy, 1 h post-inoculation. Estimates of the percent surface
coverage were calculated by densitometry on 8 independent fields of view for each strain (mean 6 SD). The images shown are one-sixth of a field of
view. (C) HA-tagged LapA protein from cell extracts (Cell) and culture supernatants (Supe) of the indicated strains is shown by Western blot, probed
with anti-HA antibodies. (D) LapA on the surface of intact cells visualized by immunoblot (top), and quantified by densitometry (bottom; mean 6 SD,
n=3). Pixel density values were scaled to set WT level at 100. (E) A biofilm assay examining the dependence of the DlapG mutant phenotype on lapA.
(F) The abundance of LapGHA and GFP in whole cell (Cell), spheroplast (Spher), and periplasmic (Peri) fractions, after normalization to total protein
concentration, is shown by Western blot.
doi:10.1371/journal.pbio.1000587.g001
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LapG contains a putative Sec secretion signal (probability 0.85;
www.cbs.dtu.dk/services/signalP) but no transmembrane do-
mains, and thus is predicted to be periplasmic. To test this
proposed localization of LapG, we used osmotic shock to release
periplasmic proteins and compared the relative proportion of
LapG in this periplasmic fraction versus the remaining sphero-
plasts. We utilized the lapGHAREST strain expressing GFP to
provide a control for tracking cytoplasmic proteins. GFP localized
exclusively to the spheroplasts, where it was enriched relative to
whole cell lysates (Figure 1F). In contrast, LapGHA was enriched
in the periplasmic fraction and depleted in the spheroplasts. These
data suggest that LapG resides in the periplasm.
LapG Modifies the LapA Protein
Noting the absence of LapA in the supernatant and its
accumulation on the cell surface of the lapG mutant, we
hypothesized that LapG functions to modify and release LapA
from the cell. A smaller variant of LapA, Mini-LapA, was
generated to assess modification of this large protein (,520 kDa).
Mini-LapA consists of the N- and C-termini of LapA, flanking an
internal myc-epitope tag (Figure 2A, top). Mini-LapA was
introduced on a multi-copy plasmid to WT and DlapG strains
and its secretion and cell-surface localization were assessed. Mini-
LapA localized to the cell-associated (Figure 2B) and supernatant
fractions (unpublished data), indicating that it is still secreted.
However Mini-LapA does not appear to be functional for
adhesion, as it cannot complement a lapA mutant (unpublished
data). We observed a difference in the apparent size of secreted
Mini-LapA isolated from strains with or without LapG: in the
presence of LapG (i.e., the WT genetic background), Mini-LapA
migrates at a smaller size, approximately 130 kDa. In contrast,
Mini-LapA in DlapG migrates at its predicted size of 145 kDa
(Figure 2B). This result suggests that LapG is required for a change
in molecular weight of Mini-LapA. Given the predicted function
of LapG, as a cysteine protease [28], the modification to Mini-
LapA was likely proteolytic cleavage.
We developed an assay to assess the necessity of LapG for Mini-
LapA modification. Unmodified Mini-LapA was prepared from a
cell extract of the DlapG mutant overexpressing Mini-LapA. This
Mini-LapA substrate was incubated at room temperature for
30 min with cell extracts prepared from the DlapG mutant, the
DlapG mutant carrying an empty vector, and the DlapG mutant
carrying a plasmid overexpressing LapG. Reactions were then
analyzed by Western blotting to reveal that Mini-LapA modifica-
tion only occurs in the presence of LapG (Figure 2C). This result
suggests a model in which LapG functions to modify the LapA
protein through proteolytic cleavage of 10–15 kDa from LapA.
LapG Is a Cysteine Protease
We hypothesized that LapG cleaves 10–15 kDa from the N-
terminus of Mini-LapA, as the C-terminus of LapA contains
residues necessary for type I secretion. To test this hypothesis, we
constructed another surrogate LapG substrate, N-Term-LapA,
consisting of the first 235 amino acids of LapA with a 6xhistidine
(6H) epitope tag at its C-terminus (Figure 2A, bottom). N-Term-
LapA and LapG-6H were each purified by nickel affinity
chromatography, then incubated together for 15, 60, and
120 min. Subsequent Western blotting revealed that LapG-6H is
necessary and sufficient for N-Term-LapA modification in vitro
(Figure 2D). Modification occurs in a time-dependent manner and
results in a 10–15 kDa reduction in the apparent molecular weight
of N-Term-LapA, consistent with the observations of Mini-LapA
above.
LapG contains a conserved domain of unknown function
(DUF920), proposed to constitute a family of Bacterial Transglu-
taminase-like Cysteine Proteinases (BTLCPs) [28]. In the study
identifying BTLCPs, the authors note that BTLCPs contain a
conserved C-H-D catalytic triad. We tested the requirement for
the cysteine of LapG’s catalytic triad for LapA modification, by
mutating C135 of LapG to alanine. Even after incubation with N-
Term-LapA for 2 h, purified LapG-C135A did not modify N-
Term-LapA. As a control, the WT LapG completely converted
the N-Term-LapA substrate in this time (Figure 2E).
Given the inactivity of LapG-C135A, we predicted that this
mutation would disrupt LapG’s function in vivo. We expressed this
mutant on a multi-copy plasmid in the DlapG strain and assessed
the effect of biofilm formation, relative to the WT allele. As
mentioned above, expressing WT LapG from a plasmid resulted
in a loss of biofilm formation (Figure 2F). The strain expressing the
C135A mutant showed a hyper-adherent biofilm phenotype,
comparable to that of the DlapG mutant. Together, these data
show that LapG’s cysteine residue is required for N-Term-LapA
modification and that LapG’s activity is required for WT biofilm
formation. This suggests a model in which cleavage of the LapA
protein by LapG is necessary for release of the adhesin from the
cell.
Appropriate Localization of LapA Requires a Functional
LapG Cleavage Site
To identify the site where N-Term-LapA is cleaved by LapG,
modified and unmodified N-Term-LapA samples were purified and
sequenced by Edman degradation. N-terminal sequencing revealed
that the first 10 amino acids of modified N-Term-LapA are
AGPSAAGTGG. These residues correspond to residues 109–118
of unmodified N-Term-LapA and chromosomally encoded LapA.
Therefore,LapG functionsto proteolytically cleave108amino acids
from the N-terminus of N-Term-LapA (Figure 3A). A BlastP search
with the LapG sequence helped us identify a number of LapA-like
proteins encoded near LapG homologs in other bacteria. Upon
aligning the N-termini of these putative adhesins, we found some
residues were conserved at the site where LapA is cleaved, including
alanines 108 and 109 that flank the site, as well as the position of this
site relative to the N-terminus (Figures 3B and S1).
To test if conserved residues in LapA are important for
recognition and/or cleavage by LapG, we constructed a mutant
N-Term-LapA replacing both alanines 108 and 109 with arginine
(AA-RR). Cellular extracts were prepared from WT and DlapG
strains expressing WT or mutant N-Term-LapA variants and N-
Term-LapA cleavage was assessed by Western blot. We observed
that LapG is unable to cleave N-Term-LapA-AA-RR variant
(Figure 3C), suggesting that the alanines at positions 108 and/or
109 are critical for LapG cleavage of N-Term-LapA in vitro.
The phenotype of C135A suggests that LapG-dependent
cleavage of the first 108 amino acids from the N-terminus of
LapA is required to release LapA from the cell surface in vivo. We
therefore hypothesized that an AA-RR mutation in full-length
LapA would block LapG activity in vivo and result in a hyper-
adherent biofilm phenotype due to accumulation of LapA at the
cell surface. We introduced the AA-RR mutation into the
chromosomal copy of lapA by allelic replacement and assessed
the biofilm phenotype. The strain expressing LapA-AA-RR forms
a hyper-adherent biofilm compared to the WT, although less so
than that observed for the lapG mutant (Figure 3D). Next we
examined the effect of the AA-RR mutation on LapA accumu-
lation. Quantitative dot blot analysis showed much higher LapA
levels on the cell surface of the lapA-AA-RR strain compared to the
WT, approaching the abundance observed for the DlapG mutant
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PLoS Biology | www.plosbiology.org 4 February 2011 | Volume 9 | Issue 2 | e1000587Figure 2. LapG modifies the LapA protein. (A) Diagrams of LapA constructs: Mini-LapA contains the N-terminal and C-terminal portions of LapA
with 3,788 amino acids of the central, repetitive region of the protein replaced by a Myc tag. The predicted molecular weight of this protein is
145 kDa. N-term-LapA contains the N-terminal 235 amino acids of LapA fused to a 6H tag at its C-terminus. The predicted molecular weight of N-term
LapA is 25 kDa. (B) Cell-associated fractions of WT and DlapG strains were probed for Mini-LapA by Western blot. The blot shown highlights the
difference in apparent molecular weight of Mini-LapA from these strains. (C) Mini-LapA isolated from the DlapG strain was treated with cell extracts
from the strains indicated above. Cleavage of Mini-LapA from 145 kDa to 130 kDa after treatment with a LapG-containing lysate is shown by Western
blot. (D) Purified N-Term-LapA (25 kDa) is cleaved to 15 kDa in a time-dependent manner upon addition of purified LapG, visualized by Western blot.
(E) Purified N-Term LapA is cleaved by LapG but not the LapG-C135A mutant, after 120 min of incubation in vitro, shown by Western blot. (F) A
biofilm assay examining the ability of pLapG-6H C135A to reduce biofilm formation by the DlapG strain, relative with the empty vector (pMQ72) and
pLapG-6H controls. Below: The abundance of LapG-6H and LapG-6H C135A in cell lysates is shown by Western blot.
doi:10.1371/journal.pbio.1000587.g002
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LapA, suggesting comparable levels of LapA protein expression
(Figure 3F). We saw a reduction in LapA in the culture
supernatant of lapA-AA-RR relative to WT (down 27% 6 11%
SD, n=4) but not a complete loss, as observed in the DlapG mutant
(Figure 3F). These results suggest that while the AA-RR mutation
eliminates cleavage of N-Term-LapA in vitro, this mutation only
partially blocks LapG cleavage of LapA in vivo. In support of this
interpretation, introducing a lapG mutation into the lapA-AA-RR
strain background yielded a hyper-adherent biofilm indistinguish-
able from the DlapG mutant phenotype. Importantly, these results
support a model in which cleavage of the first 108 amino acids
from the N-Terminus of LapA by LapG is the mechanism
required to release LapA from the cell surface in vivo.
Figure 3. Functional analysis of LapA’s cleavage site. (A) N-Term-LapA protein was sequenced by Edman degradation before and after
treatment with LapG; the samples are shown analyzed by Western blot. The amino acid sequence determined for cleaved N-Term-LapA begins with
Alanine 109 of the full-length protein. The arrows indicate the inferred site at which LapG cleaves LapA. (B) Alignment of putative adhesins identified
by their proximity to LapG homologs. The arrow indicates the cleavage site; numbers indicate amino acid position. Organism names and an
expanded alignment can be found in Figure S1. (C) Modification of WT N-Term-LapA and the cleavage site mutant (AA-RR) is compared in cell extracts
with and without LapG, as visualized by Western blot. (D) A biofilm assay examining a strain carrying a chromosomal AA-RR mutation in full-length
LapA, compared to that of the WT and DlapG strains. (E) LapA levels on the cell surface of the indicated strains are shown by dot blot (mean 6 SD,
n=12). (F) LapA protein from cell extracts (Cell) and culture supernatants (Supe) is shown by Western blot.
doi:10.1371/journal.pbio.1000587.g003
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The effects of the lapG deletion on cell attachment and LapA
localization are precisely opposite those of a lapD mutant
(Figure 4B,C). Our previous work showed that lapD is required
for maintenance of LapA on the cell surface; conversely, gain-of-
function mutations in LapD result in biofilm and LapA
localization phenotypes similar to that of a lapG mutant [17].
Given that LapD and LapG play opposing roles in regulating
attachment via LapA, we predicted that they might function in the
same pathway, and thus analyzed their genetic relationship.
The lapG and lapD genes occur in a putative operon adjacent to
the genes encoding LapA and LapEBC, the ABC transporter
required for LapA secretion (Figure 4A). We made a clean deletion
of lapG-lapD and tested this strain for biofilm formation. As shown
in Figure 4B and C, the lapG lapD double mutant (DlapGD) has a
hyper-adherent biofilm phenotype and increased cell surface
LapA, indicating that lapG is epistatic to lapD and that LapG likely
acts downstream of LapD in controlling LapA localization.
Introduction of both genes on a plasmid (pLapGD) to DlapGD
was sufficient to restore WT biofilm and cell surface LapA levels
(Figure 4B,C). A plasmid on which each ORF was epitope-tagged
(pLapGHA-LapD6H) also complemented DlapGD (unpublished
data) and was used for protein interaction studies described below.
To further explore the opposing effects of lapG and lapD on
LapA localization and biofilm formation, we overexpressed each
gene individually, then both simultaneously in the WT strain.
Overexpressing either lapG or lapD individually phenocopied the
mutant phenotype of the other gene in our biofilm assay
Figure 4. Epistasis and overexpression analyses of lapG and lapD. (A) A diagram depicting the lap region in the P. fluorescens Pf0-1 with gene
names (above) and numbers (below). As shown gene sizes are approximately to scale. (B) A biofilm assay assessing the necessity of lapG for the lapD
mutant phenotype. (C) The level of LapA on the surface of intact cells is quantified for strains appearing in (B) by dot blot (mean 6 SD, n=3). (D) A
biofilm assay assessing the effects of overexpressing the indicated genes from the PBAD promoter on pMQ72 by addition of 0.2% arabinose. (E) LapA
levels on the cell surface are shown by dot-blot, and levels in cell extracts (Cell) and supernatant (Supe) are shown by Western blot for the same
strains analyzed in (D); the growth medium contained 0.2% arabinose.
doi:10.1371/journal.pbio.1000587.g004
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formation, while overexpression of lapD increased biofilm to levels
near those of a lapG mutant. Importantly, expression of both genes
together from the same plasmid caused no change in biofilm
formation by the WT strain, indicating that the relative dosage of
each protein causes the observed effects on biofilm (Figure 4D).
We next examined the localization of the LapA protein in each
strain. Overproduction of LapD increased LapA in the cell and at
the cell surface, but decreased the amount in the supernatant
(Figure 4E). Overproduction of LapG had the opposite effect:
reducing cellular and cell surface LapA, while increasing the
amount in the supernatant. Overexpression of both genes had no
effect. Taken together, with the mutant and epistasis analyses,
these data confirm that lapG and lapD exert opposing forces on the
maintenance of LapA on the cell surface and suggest that they act
in the same pathway.
c-di-GMP Inhibits LapG Activity in a LapD-Dependent
Manner
The genetic relationship between lapG and lapD predicts a
pathway in which LapD controls LapA localization through
regulation of LapG’s protease activity. Our previous work
suggested a model whereby LapD is a transmembrane signaling
protein that binds c-di-GMP via an EAL domain in the cytoplasm,
and transmits this signal through a HAMP domain to a
periplasmic output domain (Figure 5A) [17]. We reasoned that,
when bound to c-di-GMP, LapD might inhibit LapG activity
through an interaction in the periplasm.
To test this model, we first analyzed the effect of c-di-GMP on
LapG’s cleavage of N-Term-LapA in vitro. Addition of c-di-GMP
to the lysis buffer in which cell extracts were prepared showed a
dose-dependent inhibitory effect on LapG activity, consistent with
first order binding kinetics (Figure 5B). Three replicate data sets
were obtained for this assay and quantitative densitometry was
used to determine the percentage of substrate cleaved at each
concentration of c-di-GMP. A curve was fit to each data set and
we estimated an average IC50 of LapG for c-di-GMP:
2.361.1 mM (Figure S2A). This value is similar to the estimated
affinity of the LapD protein for c-di-GMP, a Kd of 5.5+2.8 mM,
obtained using different methodology [17].
We next tested if inhibition of LapG activity by c-di-GMP
requires LapD. Cell extracts from the lapD mutant carrying the
empty vector pMQ72, pLapD, or pLapD mutant variants were
assayed for LapG activity in the presence or absence of 50 mMc -
di-GMP. Consistent with the results obtained with WT extracts, c-
di-GMP addition eliminated LapG activity in extracts with
functional LapD (DlapD pLapD; Figure 5C). However, in extracts
that lacked LapD (DlapD pMQ72 strain), there was no effect of c-
di-GMP addition on LapG activity.
To test the functional requirements for inhibition of LapG by
LapD, we compared the effects of three previously characterized
LapD mutants (shown in Figure 5A; [17]). A mutation in the EAL
domain of LapD, E617A, shows a severe reduction in c-di-GMP
binding. In a cell extract containing this LapD mutant protein,
there was no inhibition of LapG by c-di-GMP (Figure 5C). The
periplasmic mutation L152P reduces signaling output from LapD,
and this LapD variant showed little LapG inhibition upon c-di-
GMP addition (Figure 5C). Finally, the DH1 mutation in the
HAMP domain of LapD results in constitutive signaling output
regardless of c-di-GMP binding. Extracts with LapD-DH1 showed
a severe reduction in LapG activity irrespective of c-di-GMP
addition (Figure 5C). These data are fully consistent with a model
in which LapD inhibits LapG activity in response to binding c-di-
GMP. The effects of each LapD mutation on biofilm formation
and LapA retention at the cell surface (Figure 5A) [17] are well
explained by their ability to inhibit LapG.
LapD Recruits LapG to the Inner Membrane
We observed that adding a number of different detergents
relieved inhibition of LapG in cell extracts (Figure S2B), suggesting
that membrane integrity is important for LapD to inhibit LapG.
Given this observation, we hypothesized that inhibition of LapG
activity by LapD is a consequence of LapD sequestering LapG to
the membrane in a c-di-GMP-dependent manner. To test this
idea, we looked to see if addition of c-di-GMP during cell extract
preparation affected LapG localization to the inner membrane
fraction. We prepared cell extracts of the lapG-HAREST strain,
which carries a chromosomal copy of LapG-HA at the lapG locus,
in buffer with 0, 1 and 10 mM c-di-GMP. Soluble and inner
membrane fractions were isolated as described [24]. Addition of c-
di-GMP promoted re-localization of LapG from the soluble
fraction to the inner membrane fraction in a dose-dependent
manner (Figure 6A), at concentrations consistent with the
concentrations needed to inhibit LapG activity in cell extracts
prepared under identical conditions (Figure 5B). c-di-GMP
addition did not affect LapD’s localization (exclusively in the
inner membrane), nor did it change the localization of the
cytoplasmic protein GFP (see Figure S3 for localization controls).
To determine if LapD was necessary for LapG re-localization,
we disrupted the lapD gene in the lapG-HAREST strain. When cell
fractions were prepared from the resulting strain, addition of c-di-
GMP had no effect on LapG localization (Figure 6B). Interest-
ingly, some LapG was still detected in the IM. Reintroduction of
LapD on a plasmid restored c-di-GMP-dependent re-localization
of LapG to the IM (Figure 6B). We also tested the functional
requirements for LapD’s effect on LapG by reintroducing the
three LapD variants utilized above. LapD E617A is defective for c-
di-GMP binding, shows no inhibition of LapG activity (Figure 5C),
and nearly eliminated recruitment of LapG to the IM—even with
addition of c-di-GMP (Figure 6B). The L152P mutation to LapD
reduces its output [17] and LapG inhibition (Figure 5C) and also
reduced LapG recruitment to the IM (Figure 6B). Lastly, the DH1
allele of LapD is constitutively active and strongly inhibits LapG
activity; this allele promotes almost exclusive IM localization of
LapG irrespective of c-di-GMP addition (Figure 6B).
LapG and LapD Interact
To further substantiate a direct interaction between the LapG
and LapD proteins, we assessed the ability of LapG and LapD to
co-precipitate. First, immunoprecipitation (Ip) of HA tagged LapG
was performed, and we looked for enrichment of LapD. Cell
extracts were prepared from the DlapGD strain carrying pLap-
GHA-LapD6H, in buffer with 5 mM c-di-GMP, and 0.8% Thesit
to solubilize membranes. Ip of LapGHA by the addition of anti-
HA antibody and Protein A resin resulted in co-Ip of LapD6H
(Figure 6C). When the assay was performed with a nearly identical
strain lacking only the HA epitope on LapG, Ip of LapD6H was
eliminated (Figure 6C).
We next utilized a nickel resin to pull down LapD6His and look
for LapGHA co-precipitation. Precipitations were performed
under the same conditions (5 mM c-di-GMP, 0.8% Thesit) with
the addition of 10 mM Imidazole to reduce non-specific binding
to the resin. Pull down of LapD6H enriched for LapGHA
(Figure 6D). Importantly, omission of the 6H epitope from LapD
eliminated precipitation of LapGHA (Figure 6D).
To examine the dependence of LapG-LapD interaction on c-di-
GMP, we performed reciprocal pull down assays with 0, 0.5, or
5 mM c-di-GMP. We observed little co-precipitation in the
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nucleotide was added (Figure 6E). Importantly, the concentrations
of c-di-GMP required to promote this interaction are similar for
both types of co-precipitation. These concentrations are also on
par with what is needed to recruit LapG to the inner membrane
(Figure 6A), inhibit LapG activity (Figure 5B), and are consistent
with the affinity of LapD for c-di-GMP.
Lastly, we introduced the E617A, L152P, and DH1 mutations
into the pLapGHA-LapD6H plasmid to test the functional
requirements for LapG-LapD interactions. The E617A LapD6H
Figure 5. LapD-dependent effects of c-di-GMP on LapG activity. (A) A schematic diagram depicts the LapD protein as a dimer, indicating its
domains (left) and biofilm phenotypes of strains carrying WT or LapD mutants (right). Dotted lines indicate the domain in which each mutation
occurs. (B) N-Term-LapA (25 kD) and its cleavage product (15 kD) are visualized by anti-His Western blot, after treatment with cell extracts of the WT
strain containing a range of c-di-GMP concentrations. (C) Cleavage of N-Term-LapA is visualized as in (B) after treatment with cell extracts from DlapD
strains carrying the indicated plasmids, with and without 50 mM c-di-GMP.
doi:10.1371/journal.pbio.1000587.g005
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this construct (Figure 6F). This is in contrast to the wild-type level
of expression we have seen for this mutant from the plasmid used
in our prior experiments (Figures 5C,6B; unpublished data).
Despite this, we still detected some LapGHA pull down by LapD
E617A, yet co-precipitation was not stimulated by c-di-GMP
addition. This is consistent with the E617A mutant’s defect in c-di-
GMP binding (Figure 6B). LapD L152P showed a reduced ability
to pull down LapGHA relative to the WT, both with and without
c-di-GMP addition, consistent with reduced signaling output in
this mutant (Figure 6D). Lastly, the DH1 mutation resulted in
increased co-precipitation of LapGHA by LapD in the absence or
presence of c-di-GMP, in full agreement with other data showing
this allele to be constitutively active. The effects of these three
mutations on LapD’s ability to pull down LapG are consistent with
their effects on recruitment of LapG to the inner membrane and
Figure 6. LapG interacts with LapD and is recruited to the inner membrane. (A) Subcellular fractionation was performed on the lapG-HAREST
strain with the addition of c-di-GMP at the concentrations indicated. Western blots comparing levels of LapG-HA in the soluble (Sol) and inner
membrane (IM) fractions are shown (additional fractionation controls can be found in Figure S3). (B) LapG-HA recruitment to the inner membrane is
analyzed by Western blotting for the soluble and inner membrane fractions of the indicated strains with (+) and without (2)1 0mM c-di-GMP. (C)
Immunoprecipitations with an anti-HA antibody was performed in cell extracts from the DlapGD strain expressing LapD6H and HA-tagged or
untagged LapG (with 5 mM c-di-GMP). Western blots of precipitate and input are shown probed for LapD6H. (D) Co-precipitations were performed as
in (C) but with a Nickel resin, using the DlapGD strain expressing LapGHA and 6H-tagged or untagged LapD. Blots were probed for LapGHA. (E)
Precipitates from reciprocal pull down assays performed with cell extracts containing 0, 0.5, or 5 mM c-di-GMP are analyzed by Western blot, as
indicated. (F) Nickel resin pull downs from cell extracts of strains containing pLapGHA-LapD6H with different mutations to LapD (indicated above;
with and without 5 mM c-di-GMP) are shown probed by Western blot for LapGHA and LapD6H. Blot segments in (A), (B), and (F) were taken from the
same or parallel blots developed with identical treatments and exposure time.
doi:10.1371/journal.pbio.1000587.g006
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interaction between LapG and LapD that requires c-di-GMP
binding by LapD’s EAL domain, signaling through its HAMP
domain and a functional periplasmic output domain.
LapG’s Role in the Phosphate-Dependent c-di-GMP
Signaling Pathway
In prior publications, our group has shown that extracellular Pi is
an important signal governing biofilm formation by P. fluorescens
[17,25]. In the absenceof sufficientPi,biofilmformationis inhibited
by expression of the Pho regulon (Pho). Pho expression blocks
LapA-mediated attachment in two ways: it inhibits secretion of the
LapA from the cytoplasm to the cell surface, and promotes the
release of the adhesin from the cell surface to the culture
supernatant. Pho’s effects on LapA’s cell surface localization require
depletion of cellular c-di-GMP by the Pho-regulated PDE RapA
[25], and signaling through LapD [17]. In this study, we uncovered
evidence that the output of LapD signaling is control of LapG. We
next sought to test the necessity and sufficiency of the RapA-LapD-
LapG signaling pathway for control of biofilm formation via LapA
localization and secretion, in low Pi conditions.
First, we assessed the ability of the DlapG mutation to suppress the
effects of constitutive Pho regulon expression on biofilm formation.
The pst mutant constitutively expresses Pho irrespective of Pi levels
[29]; this mutation causes inhibition of biofilm formation even in
high Pi medium (Figure 7A) [25]. Deletion of rapA in the pst mutant
partially restores biofilm formation, to ,70% that of the WT
(Figure 7A). Pho regulon control of biofilms involves lapD,a st h e
DpstDrapA lapD mutant cannot form a biofilm, and constitutively
active lapD DH1 suppresses the pst mutation. Finally, deletion of
lapG in the pst mutant leads to a hyper-adherent biofilm phenotype,
despite constitutive Pho expression in this strain (Figure 7A). The
level of biofilm formation by the DlapG pst strain is less than that of
DlapG, but comparable to what is observed in the DlapD pst pDH1
strain (Figure 7A). These results show that LapG plays a critical role
in suppression of biofilm formation by the Pho regulon.
LapG Is Required for Biofilm Detachment Induced by Pi
Starvation
To gain insight into the dynamic response of LapD and LapG
to changes in cellular c-di-GMP concentration, we evaluated the
effects of physiological Pi-starvation on pre-formed biofilms. In this
Figure 7. The role of the LapD-LapG system in regulation of biofilm formation by phosphate. (A) Biofilm assay documenting the impact
of constitutive Pho regulon induction (via the pst mutation) on biofilm formation in high Pi medium (mean 6 SD, n=12). Constitutively active
lapDDH1 and the DlapG mutation are dominant over the pst mutation. (B) Physiological Pi starvation leads to detachment of biofilms from the culture
well over time (see Figure S4). Here, this process is tracked by plotting the percent stained biomass attached to the well in low Pi versus high Pi
medium for the indicated strains (mean 6 SD, n=6). (C) LapA from the whole cell fraction (Cell) into the culture supernatant (Supe) is visualized by
Western blot for the indicated strains, grown in high (Hi) and low (Lo) Pi. (D) LapA on the cell surface is quantified by dot blot for
samples0020analyzed in (C) (mean 6 SD, n=3). Blot segments in (C) and (D) were taken from the same or parallel blots developed with identical
treatments and exposure time.
doi:10.1371/journal.pbio.1000587.g007
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Pi media up to 5.5 h post-inoculation. At this time (designated
t=0) biofilms in low Pi medium began to disperse, while those in
high Pi persisted at a relatively constant level for the duration of
the assay (Figure 7B; biofilm images are in Figure S4). After
90 min, the WT strain showed a 70% reduction in attached
biomass in low Pi, relative to the high Pi condition. The DphoB
mutant showed no reduction in biofilm in low Pi, consistent with
biofilm detachment requiring the activation of the Pho regulon.
The rapA mutation partially rescues biofilm formation in low Pi
[25], and here showed only 40% reduction in biofilm after 90 min
in low Pi (Figure 7B). Both the DlapG and DlapD pDH1 biofilms
were unaffected by Pi starvation, showing no detachment in low
Pi. These data show that Pho regulon induction leads to
detachment of biofilms from the surface, and that this process
requires RapA, LapD, and LapG.
LapA Localization in Response to Pi Starvation
Pho induction inhibits secretion of LapA from the cytoplasm to
the outer membrane, and also promotes its release from the cell
surface into the culture supernatant [25]. To test if the RapA-
LapD-LapG pathway is genetically sufficient to explain these
effects, we monitored LapA localization under high and low Pi
conditions in the WT, rapA, lapD, and lapG mutants. Consistent
with our prior work, the WT strain accumulated LapA in the
cellular and supernatant fractions under low Pi conditions
(Figure 7C). These changes were accompanied by an 80%
reduction in LapA on the cell surface when cells are grown in
low Pi (Figure 7D). In contrast, the rapA mutant showed no
apparent differences in LapA secretion between high and low Pi,
and had <WT levels of cell surface LapA in both conditions
(Figure 7C,D). These observations corroborate previous data
implicating rapA in Pho control of both secretion and cell surface
localization of LapA [25]. They suggest that c-di-GMP depletion
by RapA impacts LapA in two ways: inhibiting its secretion from
the cytoplasm to the outer membrane, and promoting release from
the cell.
The lapD mutant exhibited little cell surface LapA, and
abundant accumulation of LapA in the supernatant fraction
irrespective of Pi concentration (Figure 7C,D). In high Pi, DlapD
shows reduced LapA levels in the cellular fraction relative to WT,
as reported [17]. Despite this, DlapD still accumulated intracellular
LapA in low Pi (Figure 7C). This implies that, in contrast with the
necessity of LapD for regulating LapA release from the cell
surface, RapA controls LapA secretion in a LapD-independent
manner.
In low Pi, the DlapG strain showed hyper-accumulation of LapA at
the cell surface, comparable to that seen in high Pi (Figure 7D). While
DlapG did not release LapA into the supernatant fraction in either
high or low Pi, it did show some increase in cellular LapA in low Pi
(Figure 7C). Taken together, these data suggest signaling through
LapD and LapG is required for release of LapA from the cell surface
in response to c-di-GMP depletion by RapA (detailed in Figure 8).
Our data also suggest that c-di-GMP depletion inhibits LapA
secretion by a yet-unidentified LapD-independent mechanism.
Discussion
c-di-GMP plays a key role in integrating cellular and
environmental signals into a bacterium’s decision to swim or
stick. Recent studies highlight that c-di-GMP can impact varied
outputs by binding to effector proteins, including transcription
[13,14,15], protein localization [16], flagellar motility
[9,10,11,12], and EPS synthesis [6,7,8]. While the ubiquity and
diversity of c-di-GMP signaling pathways is evident, the details of
how c-di-GMP effector proteins sense and respond to their ligand
are just beginning to emerge.
In P. fluorescens we observed release of the LapA adhesin from
the cell surface in response to phosphate limitation [25]. Here we
have closed a key gap in the c-di-GMP signaling pathway
responsible for this effect. Together with our previous work, this
study shows that LapA release depends on c-di-GMP depletion by
the PDE RapA, signaling from the cytoplasm to the periplasm by
the c-di-GMP effector LapD, and cleavage of the N-terminus of
LapA by the protease LapG. To our knowledge, this is the most
complete description of a c-di-GMP signaling ‘‘circuit’’ to date,
linking a molecular chain of events from environmental signal to
output.
Relay of a second messenger signal across the inner membrane
to affect an extra-cytoplasmic output is a new paradigm in
bacterial signal transduction. In the companion manuscript,
Navarro et al. [26] describe structural and functional analyses of
LapD, providing significant mechanistic insight into how inside-
out signaling works. LapD has two stable conformations,
autoinhibited and activated, and c-di-GMP binding drives
conversion from the one state to the other. In the autoinhibited
conformation, the ‘‘empty’’ EAL domain interacts with the other
cytoplasmic domains, likely applying some force on the periplas-
mic domain and preventing it from interacting with LapG.
Mutations that disrupt autoinhibtion cause hyper-adherent
phenotypes in vivo, akin to that seen for the DH1 mutant
described here (data in [26]). Our data are consistent with the
DH1 mutation uncoupling autoinhibition from the output domain,
thus causing constitutive interaction with LapG.
The L152P mutation in LapD causes reduced biofilm formation
and impairs interaction with LapG, underscoring the importance
of the periplasmic domain for LapD’s output. How this mutation
may alter LapD’s conformation is not clear, as it is C-terminal to
the periplasmic domain crystal structure (Navarro et al., [26]).
Structure/function analyses of interactions between the purified
periplasmic domain of LapD and LapG in vitro demonstrate that
this domain is necessary and sufficient for LapG binding (Navarro
et al., companion manuscript).
How does LapD inhibit LapG activity? One model is that
LapD simply sequesters LapG at the inner membrane from its
outer membrane substrate, LapA (Figure 8). It is also possible that
LapD inhibits LapG enzymatic activity through allosteric or
competitive means. We found no support for the latter
hypothesis, observing cleavage of N-Term-LapA under in vitro
conditions in which we demonstrate LapD and LapG interact
(e.g. in the presence of c-di-GMP). Also, addition of excess LapD
output domain had no effect on LapG activity in vitro assays with
purified components (our unpublished data). These data argue for
a simple sequestration model, though additional regulation
cannot be ruled out.
We predict that LapG cleaves LapA in the periplasm (Figure 8).
This prediction would require the N-terminus of LapA to span the
outer membrane, a possibility that has yet to be investigated. LapA
contains RTX motifs, which, in other proteins, can mediate
interaction with and insertion into membranes [30] lending some
credence to this idea. The LapG cleavage site appears to be
conserved in the N-termini of other putative adhesins
(Figures 3B,S1) suggesting that adhesin modification is a conserved
function of LapG homologs. Additional bioinformatic analyses
indicate that LapD and LapG homologs are co-conserved in
putative operons, near ABC transporters and their substrates,
indicating that this effector system is likely to regulate adhesin
localization in many other bacteria (in [26]). A recent study on a
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evidence in support of this hypothesis [31].
Here we observe that activation of LapG’s protease activity
under low Pi conditions leads to dissolution of established P.
fluorescens biofilms. Pho regulon induction in planktonic cells also
inhibits their ability to initiate biofilms, likely due to release of
LapA from the cell surface [25]. This deficiency does not impact a
cell’s propensity to contact the surface, however. Instead loss of
LapA specifically blocks the transition from a reversible association
to more stable, ‘‘irreversible’’ attachment [25]. Our data put c-di-
GMP signaling through the LapD-LapG system at the crux of this
regulatory step. The extreme phenotypes that can result from
mutations to LapD, ranging from biofilm defective to hyper-
adherent (Figure 5A), suggest that regulation of LapA localization
by LapD-LapG sets an equilibrium between stable attachment and
detachment. Loosely attached cells receiving signals that an
environment is favorable may accumulate enough c-di-GMP to
inhibit LapG, and initiate and maintain stable attachment via
LapA. Cells that do not receive favorable signals, or firmly
attached cells that sense environmental/nutritional cues that ‘‘life’’
is getting worse can activate LapG, allowing the cell to pick up and
leave. The involvement of the LapD-LapG system in regulating
both attachment to and detachment from surfaces is unique
among described biofilm pathways. Whether the intrinsic
reversibility of this system is common to other c-di-GMP signaling
systems that regulate biofilm formation remains to be seen.
Materials and Methods
The Supporting Information section includes additional mate-
rials and methods information (Text S1).
Plasmid and Strain Construction
Strains and plasmids were constructed using standard molecular
biology techniques and are listed in Table 1. Oligonucleotides used
in this study are listed in Text S1. Detailed descriptions of strain
and plasmid construction procedures can be found in the
Supporting Information (Text S1).
Figure 8. A model for regulation of biofilm formation by phosphate. This diagram depicts a summary of the current model for how Pi
concentrations control biofilm formation in P. fluorescens. Left: In high Pi conditions, c-di-GMP accumulates in the cell. LapD binds c-di-GMP and
sequesters LapG at the inner membrane, promoting the maintenance of LapA on the cell surface. Under these conditions, cells form irreversible
attachments to the substratum and can go on to form a biofilm. Right: When low extracellar Pi is sensed by the PhoR/Pst system complex, the PhoR
kinase is activated, and in turn phophorylates PhoB. PhoB,P forms a dimer and binds to the Pho Box sequence upstream of rapA, activating its
transcription. The RapA protein cleaves c-di-GMP to form pGpG, which depletes cellular c-di-GMP, leading to dissociation of c-di-GMP from LapD.
Without c-di-GMP bound, LapD cannot interact with LapG, and LapG in turn cleaves the N-terminus of LapA in the periplasm, promoting its loss from
the cell surface. Release of LapA from attached cells promotes their detachment from the substratum, and LapA loss from planktonic cells inhibits
further surface attachment.
doi:10.1371/journal.pbio.1000587.g008
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Strain or Plasmid Genotype or Description Reference
Echerichia coli
Top 10 Relevant characteristics: recA1 araD139 D (ara-leu)7697 Invitrogen
S17-1(lpir) thi pro hsdR2 hsdM+ DrecA RP4-2::TcMu-Km::Tn7 [33]
DH5a supE44 lacU169(80lacZM15) hsdR17 thi-1 relA1 recA1 [34]
Pseudomonas fluorescens
Pf0-1 Wild type [35]
DlapG Pf0-1 with unmarked deletion of lapG This study
lapGREST DlapG mutant with restored WT sequence This study
lapGHAREST lapGREST with an internal HA epitope This study
DlapG lapA DlapG::pKO-lapA This study
lapA Pf0-1::pKO-lapA [25]
DlapG lapA-HA DlapG expressing lapA-HA This study
PF-013 Pf0-1 expressing lapA-HA [25]
lapA AA108-109RR PF-013 with point mutation AA108-109RR in lapA-HA This study
DlapD Pf0-1 with unmarked deletion of lapD [17]
DlapGD Pf0-1 with unmarked deletion of lapGD This study
DlapD lapA-HA DlapD expressing lapA-HA [17]
DlapGD lapA-HA DlapGD expressing lapA-HA This study
lapGHAREST lapD lapGHAREST::pUCK-lucK-lapDKO This study
pst Pf0-1::pKO-pstC [17]
DpstDrapA Pf0-1 with deletions of pstSCAB-phoU and rapA;G m
r [25]
DpstDrapA lapD DpstDrapA::pUCK-lucK-lapDKO [17]
DlapD pst DlapD::pKO-pstC [17]
DlapG pst DlapG::pKO-pstC This study
DrapA Pf0-1 with unmarked deletion of rapA [25]
rapA lapA-HA PF-013::pKO-rapA This study
lapD::lapD6H DlapD with the lapD6H gene integrated into the native locus [17]
Plasmids
pMQ30 allelic replacement; sacB aacC1 ColE1 oriT CEN4 URA3 [36]
pEX18-Tc allelic replacement; sacB tet
r ColE1 oriT [37]
pEX18-LapGKO allelic replacement construct for deletion of lapG This study
pMQ30-LapGKI allelic replacement construct for restoration of lapG ORF This study
pMQ30-LapGHA-KI allelic replacement construct for introducing lapGHA This study
pKO-lapA Single cross-over knockout vector for lapA derived from pKO3 [25]
pKO-rapA Single cross-over knockout vector for rapA derived from pKO3 [25]
pMQ80 pMQ72 with GFP expressed from PBAD [36]
pMQ71 pseudomonas expression vector; Gm
r,K m
r [36]
pMini-LapA pMQ71 expressing mini-lapA with the addition of myc tag This study
pMQ72 pseudomonas expression vector; Gm
r [36]
pN-Term-LapA pMQ72 expressing N-Term-lapA-6H This study
pN-Term AA108-109RR pN-Term LapA with mutation AA108-109RR in N-Term-LapA This study
pMQ30-LapA108-109RR-KI allelic replacement construct for introducing lapA AA108-109RR This study
pLapG pMQ72 expressing lapG This study
pLapG6H pLapG with the addition of six histidine codons to lapG This study
pLapG-C135A pLapG6H with point mutation C135A in LapG This study
pMQ30-OperonKO allelic replacement construct for deletion of lapGD This study
pLapD pMQ72 expressing LapD [17]
pLapD6H pMQ72 expressing LapD6H [17]
pLapGHA pMQ72 expressing LapG with internal HA epitope tag This study
pLapGLapD pMQ72 expressing LapGD This study
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Strains were grown statically for 6 h in K10T-1 (high Pi)
medium, and biomass was stained with 0.1% crystal violet and
quantified as described [25]. Data presented are means 6
standard deviation (SD), n=12, unless noted otherwise. For
microscopy of surface attachment, strains were grown in K10T-1,
and the air liquid interface imaged by phase contrast microscopy.
Percent surface coverage was estimated by density measurements
of digital images using ImageJ software (NIH.gov). A detailed
description of the imaging and analysis procedure is in Supporting
Information (Text S1). To analyze the effects of Pi starvation on
biofilms, low Pi medium (K10T-p) medium was used [25].
LapA Localization
For Western and dot blots of the LapA protein, we utilized
strains with an internal 3xHA tag in chromosomal lapA [25].
Overnight cultures were diluted 1:75 into K10T-1, grown for 6 h
at 30uC, shaking at 230 rpm. Preparation and analysis of samples
for LapA localization were performed as described previously [25].
Detection of cell surface LapA by dot blot was performed on
aliquots of whole cells from the same cultures grown for LapA
localization; blotting and quantification were performed as
described [17]. In experiments monitoring the effects of Pi
starvation on LapA localization, cultures were grown in high
and low Pi media for 6.5 h.
LapG Localization
Cultures were grown in the same manner as for LapA
localization. The periplasmic fraction was obtained by incubation
in osmotic shock buffer (50 mM Tris pH8, 20% sucrose, 2 mM
EDTA) for 20 min at RT, followed by 10 min centrifugation at
15,0006 g to pellet spheroplasts. For tracking the effect of c-di-
GMP on LapG, periplasmic fractions were not prepared. Instead,
clarified cell lysates were separated into soluble and membrane
fractions by ultracentrifugation, 1 h at 100,0006 g, and inner
membranes were isolated by solubilization in 1% sarkosyl as
described [24].
Purification of Proteins
Purification of the histidine-tagged LapG, LapG-C135A, and
N-Term-LapA from E. coli was performed using standard Nickel
affinity chromatography techniques, as described [32].
LapG Activity Assays
Cell extract preparation. Bacterial cultures were grown in the same
manner as for LapA localization. Clarified cell extracts were
prepared by sonication (4610 s on ice) in resuspension buffer,
followed by centrifugation 12 min at 15,0006g.
Activity assays with Mini-LapA and N-Term-LapA.T oa s s e s s
cleavage of Mini-LapA, cell extracts from DlapG pMini-LapA
were mixed 1:1 with cell extracts from strains with and without
LapG to test their activity, and incubated at RT for 30 min.
Activity assays with purified protein were performed in
resuspension buffer: 750 ng N-Term-LapA (,30 pmol; est.
95% pure) were incubated with 750 ng of LapG (est. purity:
50%) in 37.5 ul, at RT, for 15–120 min. In assays testing the site
specificity of LapG, neither N-Term-LapA AA-RR nor N-term
LapA were purified. Instead cleavage by endogenous LapG was
assayed in cell extracts.
Inhibition by c-di-GMP. Chemically pure c-di-GMP (GLSynthesis
Inc.) was added at various concentrations to identical aliquots of
resuspended cells prior to sonication for cell extract preparation.
LapG activity in cell extracts was assessed by addition of 30 pmol
of purified N-Term-LapA, and incubation for 100 min at RT.
Co-Precipitations
Proteins were precipitated from clarified lysates prepared in the
same manner as for LapA localization. Immunoprecipitations,
the lysis buffer contained 20 mM Tris pH 8, 10 mM MgCl2, and
0.8% Thesit (Sigma). The same buffer was used for nickel resin
pull downs, with the addition of 10 mM imidazole. Each
immunoprecipitation contained 400 ml lysate, 40 mlP r o t e i nA
sepharose (Genscript), and 0.5 ml monoclonal, mouse anti-HA
11.1 antibody (Covance). Each nickel resin precipitation
contained 400 ml lysate, and 40 ml resin. After incubating pull
downs at 4uC for 90 min, the nickel resin (Invitrogen) was washed
265 min at RT with gentle shaking, then a third time briefly
prior to SDS-PAGE. Pull downs with c-di-GMP added were
washed with buffer containing the same concentration(s) of c-di-
GMP.
N-Terminal Sequencing
Edman degradation was performed by the Dartmouth College
Proteomics Core. Details on sample preparation are included in
the Supporting Information (Text S1).
Strain or Plasmid Genotype or Description Reference
pLapGHA LapD6H pLapGLapD with indicated epitope tag(s) This study
pLapGHA LapD pLapGLapD with indicated epitope tag(s) This study
pLapG LapD6H pLapGLapD with indicated epitope tag(s) This study
pLapDE617A pMQ72 expressing LapD E617A [17]
pLapDL152P pMQ72 expressing LapD L152P [17]
pLapDDH1 pMQ72 expressing LapD DH1 [17]
pLapGHA LapD6HE617A pLapGHA LapD6H with E617A mutation in LapD This study
pLapGHA LapD6HL152P pLapGHA LapD6H with L152P mutation in LapD This study
pLapGHA LapD6HDH1 pLapGHA LapD6H with DH1 mutation in LapD This study
pKO-pstC Single cross-over knockout vector for pstC derived from pKO3 [17]
pUC-lucK-LapDKO lapD single cross-over knockout vector derived from pUC-lucK [17]
doi:10.1371/journal.pbio.1000587.t001
Table 1. Cont.
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Figure S1 Expanded alignment of putative adhesins
possibly cleaved by LapG homologues. The LapG protein
sequence was used as query in a BlastP search. Putative LapG
homologues in related pseudomonads as well as more distantly
related bacteria were identified. The genomic context of putative
LapG homologues was searched visually for Type 1 secreted
proteins to identify putative, LapA-like adhesins. Shown are the
first 150 amino acids of 9 putative adhesins aligned with the first
150 amino acids of LapA, listed by gene name (using the AlignX
program, VectorNTI suite, Invitrogen). Light grey shading
indicates similar amino acids, dark grey indicates conserved amino
acids, black indicates amino acids identical in all sequences. The
consensus sequence is based on similar or identical residues in 7 of
10 sequences at a given position. Sequences are from the following
organisms: LapA, P. fluorescens Pf0-1; PFL_0133, P. fluorescens Pf-5;
PP_0168, P. putida KT2440; PSEEN0141, P. entomophila L-48;
ECA3266, Erwinia carotovora atroseptica; DP0516, Desulfotalea psychro-
phila LSv54; Rfer_3766, Rhodoferax ferrireducens DSM 15236;
Sden_0384, Shewanella denitrificans OS217; Bpro_0306, Polaromonas
sp. JS666.
Found at: doi:10.1371/journal.pbio.1000587.s001 (1.62 MB TIF)
Figure S2 Further characterization of LapG inhibition
by c-di-GMP in cell extracts. (A) Inhibition of LapG activity
by c-di-GMP in cell extracts was tested over a range of
concentrations, in three independent experiments. A best-fit curve
was generated to estimate the apparent IC50 in each experiment,
listed in the legend (right). (B) Cleavage of N-Term-LapA in WT
cell extracts, with and without 50 mM c-di-GMP, is assessed by
Western blot. Detergents (above) were added to the cell extracts
prior to the assay at the indicated concentrations, and mixed
gently for 1 min at room temperature. The first six blot segments
are from one experiment, and the second two (grouped by one
box) are from another. In both experiments shorter incubation
times (,40 min) were used; thus cleavage of N-Term-LapA was
not complete. In most cases, detergent addition increased LapG
activity relative to the no-addition control. In all cases, detergents
enabled N-Term-LapA cleavage in the presence of 50 mM c-di-
GMP, which completely inhibits cleavage in the absence of
detergent. Detergents: LPC C-12 is lysophosphatidyl choline C-12;
CHAPS is 3-[(3-Cholamidopropyl)dimethylammonio]-1-propane-
sulfonate; b-OG is b-octylglucoside; NP40 Alt. is nonylphenyl
polyethylene glycol alternative; TX-100 is Triton X-100.
Found at: doi:10.1371/journal.pbio.1000587.s002 (1.05 MB TIF)
Figure S3 Effects of c-di-GMP addition on the localiza-
tion of fractionation controls. Western blots analyzing four
cellular fractions, whole cell (WC), soluble (Sol), inner membrane
(IM), and outer membrane (OM), are probed for the indicated
proteins. Fractionations were performed in 0, 1, or 10 mM c-di-
GMP, as indicated above. Samples analyzed for LapGHA were
prepared from the lapG-HAREST strain as described in the text. All
other samples were prepared from a strain carrying a chromo-
somal copy of LapD6H and a plasmid expressing GFP
(lapD::lapD6H pMQ80). While LapGHA exhibits a re-localization
from the soluble to the inner membrane fraction with increasing c-
di-GMP, no other protein shows this trend. The cytoplasmic
protein GFP (lower band of the doublet in the WC fraction)
exclusively localizes to the soluble fraction, while LapD6H
exclusively localizes to the inner membrane fraction. Whole cell
and membrane fractions were also probed with an antibody that
recognizes OprF of P. aeruginosa [1], to show the relative purity of
the inner and outer membrane fractions.
Found at: doi:10.1371/journal.pbio.1000587.s003 (1.21 MB TIF)
Figure S4 Visualization of biofilm detachment during
phosphate starvation. Images of crystal violet stained micro-
titer dish biofilms, quantified (along with other replicates) for the
analysis presented in Figure 7B, are shown prior to solubilization
of the stain. While Figure 7B tracks the amount of biofilm stained
for each strain in low Pi relative to high Pi, these images provide a
visual representation of the detachment process over time. Biofilms
form in both high and low Pi medium and are roughly equivalent
at 5.5 h post-inoculation. After 5.5 h, the WT biofilm gradually
detaches from the well in low Pi medium. Detachment requires
Pho regulon expression (there is no detachment in the DphoB
mutant) and is largely explained by expression of the Pho-
regulated c-di-GMP PDE RapA (there is reduced detachment in
the rapA mutant). A constitutively active allele of LapD (DH1) and
the DlapG mutation both confer complete insensitivity to Pi
starvation.
Found at: doi:10.1371/journal.pbio.1000587.s004 (1.40 MB TIF)
Text S1 Detailed materials and methods.
Found at: doi:10.1371/journal.pbio.1000587.s005 (0.10 MB
DOC)
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